Medication info
Rabeprazole Sodium 20 mg Tablet

Rabeprazole Sodium 20 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Pharmaking Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets/PTP (28 tablets/PTP×1)
Approval status
Active

MFDS item code 200611091 · Notified 2006.11.20 · Insurance code 652300110

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcers, duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not been treated after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg may be administered orally twice daily. However, 20 mg twice daily is reserved for patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is required. After symptoms have resolved, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered concomitantly twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to individual patient needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Pharmaking Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer caused by Helicobacter pylori infection
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective for the treatment of gastric and duodenal ulcers, and is also used for symptom relief of gastroesophageal reflux disease and long-term maintenance therapy. It is used in combination with antibiotics for patients with digestive tract ulcers caused by Helicobacter pylori infection. It is also applicable for conditions of excessive gastric acid secretion, such as Zollinger-Ellison syndrome. In summary, it helps in the treatment and symptom improvement of various gastric and esophageal diseases.

How to take

Adult dose

Gastric ulcers, duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not been treated after 8 weeks of proton pump inhibitor (PPI) therapy, an additional 8 weeks of 10 mg or 20 mg may be administered orally twice daily. However, 20 mg twice daily is reserved for patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is required. After symptoms have resolved, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended that this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g be administered concomitantly twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted according to individual patient needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with allergies to certain components or who have experienced hypersensitivity reactions. Caution is required in patients with allergies to penicillin or macrolide antibiotics, especially when used in combination during Helicobacter pylori eradication therapy. It is safer for pregnant or breastfeeding women to avoid this medication. Patients with compromised liver function or the elderly may experience more severe side effects, so use with caution is necessary. If allergic symptoms such as skin rash or itching occur during medication, discontinue immediately and consult a doctor. It is important to have regular blood tests or liver function tests to monitor for any abnormal signs. Various side effects may occur in multiple body systems, including the heart, digestive system, and nervous system, so any symptoms that arise should be reported immediately. Long-term use may increase the risk of fractures due to osteoporosis, and bone density tests should be considered if necessary. Hypomagnesemia may occur rarely, so magnesium levels in the blood should be periodically monitored when used long-term or with certain medications. This drug strongly inhibits gastric acid secretion, which may slightly increase the risk of bacterial infections in the stomach; if symptoms like diarrhea persist, consult a doctor. Caution is needed for drowsiness or other symptoms when driving or operating machinery. Interactions may occur when taken with other medications, so inform healthcare providers of all medications being taken. Do not chew or crush this medication; it should be swallowed whole in tablet form, and kept out of the reach of children. It is recommended not to use in children, as clinical safety has not been established. There is no specific antidote for overdose, requiring treatment based on symptoms and supportive therapy.

Side effects

Rash, urticaria, pruritus, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, purpura, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste alteration, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenitis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbance, trembling, weakness, nervous hyperexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased circulating blood volume, limb hypotonia, sensory loss, decreased grip strength, language confusion, unsteadiness, delirium, spatial orientation disturbance, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single muscle contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urine frequency, dysmenorrhea, urinary tract obstruction, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, incontinence, interstitial nephritis, edema, total cholesterol elevation, triglyceride elevation, BUN elevation, blood thyroid-stimulating hormone elevation, chest pain, chills, fever, urinary tract infection, erythema, malaise, weight gain, visual disturbances, decreased appetite, neck stiffness, phototoxic reactions, hangover effects, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, bullous skin rash, systemic allergic reactions, arthralgia, epileptic nephritis, gynecomastia, thyroid-stimulating hormone elevation, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. When stored, it's best to keep it at room temperature, between 1 to 30 degrees Celsius. It is advisable to avoid extremely hot or cold places.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets/PTP (28 tablets/PTP×1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.